कोशिश गोल्ड - मुक्त

Trade, talent, tech on table as Merz’s visit begins today

Business Standard

|

January 12, 2026

During German Chancellor Friedrich Merz’s two-day visit to India, which begins on Monday, India and Germany are set to sign several agreements across sectors such as defence, mobility, education and skilling — including the teaching of German language in more Indian schools — investment, critical technology supply chain, green energy, and semiconductor, as Berlin is keen to double its trade with New Delhi from the current level of a little over $50 billion, with the India~European Union (EU) free trade agreement (FTA) on the anvil.

- ARCHIS MOHAN

As many as 25 chief executive officers (CEOs) of top German companies will accompany Merz to India. The German Chancellor, who is eight months into his job, will meet Prime Minister (PM) Narendra Modi in Ahmedabad on Monday, where he will also visit the Sabarmati Ashram. On Tuesday, Merz will be in Bengaluru, where he will visit the Indian Institute of Science and German firm Bosch’s offices.

Merz’s January 12-13 visit to India will be his first to Asia as German Chancellor and is also significant as it comes a fortnight before top EU leaders visit India later this month, when they are to be the chief guests at this year’s Republic Day parade and the two sides are slated to sign the India-EU FTA on January 27. Germany has been strongly backing the FTA.

Germany is India’s largest trading partner in the EU, and bilateral trade in goods and services between the two countries reached $51.23 billion in 2024-25. During his visit to India in September, German Foreign Minister Johann Wadephul met the PM and later said his country is keen to double bilateral trade, which currently stands at a little under 31 billion euros. In recent months, especially after the US increased tariffs on Indian goods to 50 per cent, New Delhi has explored diversifying its export markets.

Business Standard से और कहानियाँ

Business Standard

Labour Codes impact: HCL tech profit slips 11%

Q3 top line beats Street estimates, bottom line misses expectations

time to read

2 mins

January 13, 2026

Business Standard

New labour Codes, restructuring weigh on TCS earnings

Tata Consultancy Services (TCS), India’s largest information technology (IT) services firm, saw its profit impacted in the October-December quarter by restructuring and changes in labour Codes.

time to read

1 min

January 13, 2026

Business Standard

Business Standard

Black drives the thrill for car buyers

Sees a surge in yearly sales, while white remains practical 'utility king'

time to read

2 mins

January 13, 2026

Business Standard

CHOOSING THE RIGHT B-SCHOOL TO MATCH YOUR CAREER GOALS

Success comes when you pick an institution that fits your professional dreams and your personality, helping you become the leader you want to be

time to read

2 mins

January 13, 2026

Business Standard

Business Standard

China’s PVC rethink to help India pipe makers

Supply likely to tighten after S-PVC rebate withdrawal

time to read

2 mins

January 13, 2026

Business Standard

Responsible growth

India must ensure data centres are sustainable

time to read

2 mins

January 13, 2026

Business Standard

India’s GenZ is full of creativity: PM

Prime Minister Narendra Modi on Monday said India's GenZ is full of creativity and with innovative ideas, energy and purpose, the country’s youth is at the forefront of nation-building.

time to read

1 min

January 13, 2026

Business Standard

Business Standard

Iran wants to negotiate after threats to attack, says Trump

At least 572 killed in protests; Tehran says situation ‘under full control’

time to read

2 mins

January 13, 2026

Business Standard

Insurers knock on Irdai door for clarity on director overlap ban

CLAUSE THREATENS BOARD STRUCTURES AT BANK-BACKED FIRMS SAYS INDUSTRY

time to read

2 mins

January 13, 2026

Business Standard

Delhi HC allows Zydus to sell generic version of cancer drug

Citing public interest, the Delhi High Court has cleared the way for Zydus Life-sciences to proceed with the sale of its version of the cancer drug nivolumab in India.

time to read

1 min

January 13, 2026

Listen

Translate

Share

-
+

Change font size